Salivary gland-like tumors of the breast show a great variety of architectural patterns and cellular differentiations such as glandular, myoepithelial, squamous, and even mesenchymal phenotypes. However, currently little is known about the evolution and cellular differentiation of these tumors. For that reason, we performed an in situ triple immunofluorescence lineage/differentiation tracing (isTILT) and qRT-PCR study of basal (K5/K14), glandular (K7/K8/18), and epidermal-specific squamous (K10) keratins, p63, and smooth muscle actin (SMA; myoepithelial marker) with the aim to construct and trace different cell lineages and define their cellular hierarchy in tumors with myoepithelial differentiation. isTILT analysis of a series of 28 breast, salivary, and lacrimal gland tumors, including pleomorphic adenomas (n ¼ 8), epithelial-myoepithelial tumors (n ¼ 9), and adenoid cystic carcinomas (n ¼ 11) revealed that all tumor types contained K5/K14-positive progenitor cells in varying frequencies from a few percent up to 15%. These K5/K14-positive tumor cells were found to differentiate to glandular-(K8/18-positive) and myoepithelial-lineage (SMA-positive)-specific cells and were also shown to generate various heterologeous cell differentiations such as squamous and mesenchymal progenies. p63 was co-expressed with K5/K14 in basal-like progenitor cells, myoepithelial, and squamous cells but not in glandular cells. Our results show that the corresponding counterpart tumors of breast and salivary/lacrimal glands have identical cellular compositions. Taken together, our isTILT and RNA-expression data indicate that look-alike tumors of the breast represent a special subgroup of basal-type tumors with benign or usually low malignant potential.
be found including tumor cells showing glandular, myoepithelial, squamous, and mesenchymal phenotypes. [4] [5] [6] [7] [8] However, the evolution of these lesions in both breast and salivary glands in terms of different lineage differentiations and cells of origin are still contradictory and poorly understood. Several authors have suggested that some of these tumors arise from a single cell with the potential for divergent differentiations. 2, 9, 10 It has also been proposed that the myoepithelial cell might have a role in this context, at least in some of these lesions. 2, 11 In order to investigate this further, we have now analyzed a series of salivary gland-like tumors of the breast and their salivary/lacrimal gland counterparts, including pleomorphic adenomas, adenoid cystic carcinomas, and epithelial-myoepithelial tumors, using in situ triple immunofluorescence lineage/ differentiation tracing (isTILT) experiments, which allow direct observation of cells at different stages of differentiation. By tracing the sequential expression of basal (K5 and K14), glandular (K7 and K18, K8/18), and epidermal-specific squamous keratin (K10) [12] [13] [14] in combination with p63 15, 16 and discriminatory myoepithelial markers such as SMA, 7, [17] [18] [19] we can infer the developmental capacities of K5/K14-positive tumor cells and construct differentiation lineage trees for these tumor types.
The data presented here illustrate the cellular organization of look-alike tumors with myoepithelial differentiation of the breast and salivary/ lacrimal glands from a novel point of view. The full extent of K5/K14-positive tumor cells with their complex lineage differentiations can be appreciated and shown to be an important clue for the understanding of the evolution of these tumors. On the basis of our findings, we postulate that K5/K14-positive progenitor cells contribute to the development and differentiation of these lesions and thus confirm their basal type nature.
Materials and methods

Case Selection
Routinely processed formalin-fixed paraffin-embedded tissues from 8 pleomorphic adenomas, 9 epithelial-myoepithelial/myoepithelial tumors, and 11 adenoid cystic carcinomas of the breast and their counterparts of salivary/lacrimal gland origin were retrieved from the consultation files of the Department of Pathology of the Muenster University (WB) and Albertinen Pathology, Hamburg/Salivary Gland Registry, Hamburg (ThL). All cases were reviewed at least by two pathologists independently (WB, ThL) and classified according to previously published criteria described in the WHO Breast Tumor Classification from 2012 5, 7, 8 and the WHO Classification of Head and Neck Tumors. [20] [21] [22] [23] [24] [25] [26] Normal human breast tissue obtained from plastic surgery and normal salivary glands were used as controls.
Tissue Probe Processing and Primary Antibodies
Paraffin tissue sections (4 mm thick) were pretreated and stained as described elsewhere. 27 For immunostaining, we used primary antibodies raised against keratin K5 (rabbit monoclonal, MEDAC Diagnostica), keratins K5/6, K14, K7, K8/18, K18 and K10 (mouse monoclonals, DAKO, Sigma and Dianova), SMA (rabbit polyclonal, Abcam), vimentin (mouse monoclonal, Abcam and DAKO), Ki-67 (Rabbit Monoclonal, Thermo Fisher Scientific), and p63 (DAKO). The exclusion of the primary antibody from the immunohistochemical reaction or substitution of primary antibodies with normal IgG (mouse or rabbit) at the same final concentration as that of the primary antibodies resulted in lack of immunostaining.
Bright-field Microscopy
Following the immunoreactions with primary antibodies, the sections were treated for 10 min with methanol containing 0.6% H 2 O 2 to quench endogenous peroxidase. For bright-field microscopy, bound primary antibodies were detected with Dako LSAB REAL Detection System (Naphthol phosphate/Fast Red, no. K5005, Dako Corporation, Hamburg, Germany) or with AmpliStain horseradish peroxidase (HRP) conjugate (SDT GmbH, Baesweiler, Germany) according to manufacturers' instructions. The HRP label was visualized using the NovaRed substrate kit (Vector Laboratories, Burlingame, CA, USA). The sections were counterstained with haematoxylin. All steps were preceded by rinsing with PBS (pH 7.4).
isTILT Experiments Systematic isTILT-experiments were performed for basal, glandular (luminal), and squamous keratins as well as for SMA. For these studies, we used secondary antibodies (purchased from Dianova and Molecular Probes) conjugated with Cy3, Alexa Fluor-488, Alexa Fluor-647, or with biotin. 27, 28 For simultaneous visualization of primary antibodies of the same IgG isotype, primary antibodies were non-covalently labeled with a reporter molecule in vitro employing monovalent IgG Fc-specific Fab fragments. 29 The reporter molecule was either fluorophore Cy3 or biotin. The latter was visualized using fluorophore-labeled streptavidin. Nuclei were counterstained with DAPI (5 mg/ml PBS, 15 s), and sections were mounted with VectaShield (Vector Laboratories).
Image Acquisition
Immunostained sections were examined using a Zeiss microscope (Axio Imager Z1). Images were captured and processed using an AxioCam digital microscope Salivary gland-like tumors W Boecker et al camera and the software AxioVision image processing (Carl Zeiss Vision, Germany). The images were imported as JPEG files into PhotoImpact 3.0 (Ulead Systems, Torrance, CA, USA) and submitted with the final revision of the manuscript at 300 DPI.
Quantitative RT-PCR (qPCR)
Areas of tumor tissue were manually microdissected from tissue sections (WB). Total RNA was extracted from the microdissected tissue using the RNeasy FFPE kit (Qiagen, Germany). mRNA of keratins 5, 14, 7, 8, 18 and 10, and ACTA2 (alpha 2 SMA) was reverse transcribed and amplified using the OneStep RT-PCR kit (Qiagen, Germany). RNA expression was quantified by real time fluorescence detection of amplified cDNA (ABI life technologies, StepOne system) using MGB-probes. Gene expression levels are described as ratios between two absolute measurements (gene of interest/HPRT endogenous reference). All samples were run in triplicate for all genes. We compared the differential expression of 6 keratins (K5/K14/K7/K8/K18/K10) and ACTA2 in tumor and normal breast parenchyma or nipple squamous epithelium. 
Cell Culture
Tumor cells from a lacrimal gland adenoid cystic carcinoma were maintained in culture as previously described. 30, 31 Briefly, tumor tissue was minced into small pieces and digested in a collagenase solution (1000 U collagenase/ml) (Sigma-Aldrich) for 60 min at room temperature. The tumor cell suspension was washed twice in culture medium and seeded out in 25 cm 2 flasks. Tumor cells from passage 15 were seeded out on 8-well chambers slides (Nunc) and allowed to attach overnight. On the next day, chambers were rinsed briefly with phosphatebuffered saline (PBS) and cells were fixed in methanol for 5 min at room temperature. Slides were air-dried for 60 min and subsequently subjected to immunostaining.
MYB-NFIB Fusion Gene Screening
Total RNA was isolated from cultured adenoid cystic carcinoma cells (passage 15) as previously described. 31 DNase treated (DNA-freeTM; Ambion, Austin, TX, USA) total RNA was subsequently converted to cDNA using the SuperScriptTM FirstStrand Synthesis System according to the manufacturer's manual (Invitrogen). The MYB-NFIB fusion transcripts were amplified by PCR using previously published primer sets. 31, 32 PCR products were gel-purified and sequenced using an ABI PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
Results
Pleomorphic Adenomas
Four pleomorphic adenomas of the breast, one of which was in a papillary lesion, and four salivary pleomorphic adenomas were analyzed. All tumors showed a characteristic histological appearance with anastomosing cords of epithelial cells and abluminal cells, often with a reticular pattern and spread of these cells into the surrounding 'mesenchymal tissue' with mucoid/myxoid and/or chondroid differentiation ( Figure 1a and Supplementary Figure 1a) . 9, [33] [34] [35] In three tumors (two parotid gland and one breast tumor), we found focal squamous cell metaplasia. Conventional immunohistochemical staining revealed a great variability (Table 1 ) and the dual nature of the tumors with epithelial and myoepithelial differentiation was confirmed. 36, 37 However, in isTILT-experiments the most remarkable finding in all cases was small groups of cells with basal keratins K5/K14 as the only expressed keratins (Figures 1b-e and Supplementary Figures 1b-d ). These cells were also found to co-express p63. In some tumors, these progenitor cells amounted to 15% of the tumor cell mass. Furthermore, isTILT allowed us to follow the divergent differentiation lineages evolving from these K5/K14-positive cells. Figure 2) . p63-expression was seen only in the myoepithelial and squamous lineages and not in the glandular lineage.
Epithelial-myoepithelial Tumors
We analyzed six epithelial-myoepithelial tumors of the breast and two of the salivary glands. Four breast tumors and two salivary gland tumors showed the typical biphasic pattern with prominent myoepithelial proliferations intermingled with glandular structures (Figure 2a and Supplementary Figure 3a) . Myoepithelial cells with spindled appearance and clear or eosinophilic cytoplasm were evenly distributed in the background. Immunohistochemically, a multilayering of myoepithelial cells was usually observed outside of the glandular cells (Supplementary Figures 3b-d) , which were partly surrounded by a deposition of collagen IV-and laminin-positive basement membrane (data not shown). In other cases, we observed a solid proliferation of myoepithelial cells between glandular spaces with irregular formation of basement membrane-like material between the tumor cells (Supplementary Figure 3e) . In isTILT experiments, we observed in all tumors K5/K14-positive progenitor cells amounting to about 1% of the tumor cell population (Figures 2c and d and Supplementary  Figure 4) . Furthermore, a sequential expression of K5/K14 and glandular lineage markers K8/18 in glandular cells and K5/K14 and the myoepithelial marker SMA in spindle cells were observed in all Figures 4c-e) , indicating the evolution of these two cell lineages from K5/K14 progenitor cells. The same staining pattern could be observed in two cases of malignant adenomyoepithelioma of the breast of the spindle cell type (Supplementary Figure 5) . Interestingly, the two adenomyoepitheliomas with spindle cell pattern contained a number of hybrid-cells coexpressing keratins K5/K14, K8/18, and the myoepithelial marker SMA as well as p63. One case of adenomyoepithelioma displayed squamous differentiation evolving from K5 and/or K14-positive progenitor cells (Figures 2f-i) .
Myoepithelial Carcinoma (Malignant Myoepithelioma)
We have found only one convincing case classified as a pure myoepithelial carcinoma, which was included in this series. Monophasic tumors with additional glandular differentiation, as identified immunohistochemically by K8/18 expression, were classified as monophasic adenomyoepitheliomas (see above). The case with pure myoepithelial differentiation contained K5/14-positive cells, which coexpressed the myoepithelial marker SMA (Supplementary Figure 6) . p63 was also highly expressed in these lesions. No other lineage differentiation was observed.
Adenoid Cystic Carcinoma
Six primary adenoid cystic carcinomas of the breast-, and two salivary and three lacrimal adenoid cystic carcinomas were analyzed. All cases displayed a typical cribriform pattern dominated by basal-like cells. Many pseudoglandular lumina with eosinophilic alcian blue-positive globules and true glandular lumina containing H/E basophilic and diastase-PAS-positive secretions were found. The immunohistochemical profile observed in all cases included positivity for K5 and K14, SMA, K7/K8/18, and p63 (Table 1 ). The glandular keratins K7/K8/18 were focally found in glandular structures. The glands were nearly always p63-negative, but a number of glandular cells expressed K5/K14. All tumors displayed myoepithelial differentiation, as indicated by coexpression of K5/K14, p63 and SMA. Using isTILT, the cellular hallmark of these tumors was a mixture of few K5/K14-positive progenitor cells (about 1% of the tumor cells) in a bulk of cells (Figures 3a-d) . The myoepithelial differentiation was observed in basal-like cells and in cells in the vicinity of pseudoglandular spaces that were filled with collagen IV-and laminin-positive hyaline basement membrane-like globules or membranes.
We also studied the cellular composition and differentiation of cultured tumor cells from a lacrimal gland adenoid cystic carcinoma as well as from the primary tumor from which the cells were derived. The cultured cells had a typical epithelial morphology with small to medium-sized, rounded or cuboidal cells. Both the primary tumor and the cultured cells expressed the adenoid cystic carcinoma-specific MYB-NFIB gene fusion (data not shown). isTILT-analysis revealed that the cultured adenoid cystic carcinoma cells showed the same cellular differentiation pattern as the primary tumor (Figures 3e-h and Supplementary Figure 7) .
Normal Breast and Salivary Gland Epithelium
Based on the assumption that the cellular features of these tumors reflect (mimic) the differentiation potential of their cells of origin, we analyzed the epithelium in both organs using the isTILT experiments described above.
The ducts of both glands contained K5/14-positive progenitor cells, which differentiated to glandular cells (Supplementary Figure 7) . However, the interlobular ducts of the breast contained a luminal layer showing a mixture of K5 and/or K14-positive progenitor cells, intermediary glandular cells (K5/ K14 and K7/K8/18) and glandular cells (only K7/8/ 18). In contrast, in striated ducts of the salivary gland, K5/K14-positive progenitor cells could be found only in a basal position which co-expressed p63. The luminal layer contained glandular cells expressing K7 and K8/18. Occasionally, a sequential expression of glandular keratins K7/K8/18 and basal keratins 5/14 could be observed in striated ducts with formation of intermediary (K5/K14 and K7/K8/18) and glandular cells (K7/8/18 only). These data clearly speak for a differentiation pathway of glandular duct cells from K5/K14-positive progenitor cells.
qPCR Analyses
The expressions of basal (K5/K14) and glandular (K7/K8/K18) keratins, epidermal specific squamous keratin (K10), and ACTA2 were studied by qPCR in seven tumors with myoepithelial differentiation. As shown in Figure 4 , we found upregulation of mRNA of both basal and glandular keratins in all tumors compared with normal breast parenchyma. Similarly, the expression of ACTA2 was lower in the tumors compared with normal breast tissue with the exception of one adenomyoepithelioma (lobulated type) and two adenoid cystic carcinomas that showed the highest levels of ACTA2 expression (cases 9, 19 and 23 in Table 1 ). The expression of the epidermal-specific squamous keratin 10 was, compared with nipple epidermis, very low with a moderate level only in one pleomorphic adenoma of the parotid gland (case 6 in Table 1 ), which displayed squamous differentiation in H/E and K10 expression in immunostaining. When comparing the RNA and protein expression levels, we found that the RNA-levels of basal and glandular keratins were positively correlated with the immunohistochemical findings. Thus, the RNA data corroborated the immunohistochemical findings implying that these tumors represent basal type tumors with glandular and myoepithelial differentiation.
Discussion
Here, we present a systematic isTILT and qPCR study of a series of look-alike tumors of the breast and salivary/lacrimal glands with myoepithelial differentiation. In agreement with previous observations, our findings revealed the dual epithelial myoepithelial nature of these lesions, 3, 38 including expression of glandular (luminal) keratins K7/K8/ 18, and myoid markers such as SMA, maspin, CD10, calponin, basal keratins K5/K14, and p63. 16, [38] [39] [40] [41] [42] [43] [44] Using isTILT, we could demonstrate the cellular organization of these tumors from a novel point of view. Thus, we identified neoplastic cells in all lesions that only expressed the basal keratins K5 and K14. These cells varied in frequency from only a few percent in adenoid cystic carcinomas and up to 15% in pleomorphic adenomas and in epithelialmyoepithelial tumors. The K5/K14-positive cells co-expressed p63, and, when they lacked specific lineage markers, they were regarded as neoplastic progenitor cells. Moreover, we provide evidence that 45, 46 In one case of lacrimal gland adenoid cystic carcinoma, we had access to both cultured MYB-NFIB fusion-positive adenoid cystic carcinoma-cells and the corresponding primary tumor. The immunofluorescence stainings of the cultured cells fully corroborated the results of the primary tumor. They also confirmed the results of our isTILT-experiments, which revealed glandularmyoepithelial hybrid cells with co-expression of both glandular keratins K7/K8/18 and myoid markers such as SMA. Interestingly, the myoepithelial differentiation was usually associated with the formation of collagen IV-and laminin-positive basement membrane material, which has been shown to be a diagnostically important feature in adenoid cystic carcinoma. 42 It is well known that look-alike tumors with myoepithelial differentiation of both the breast and salivary glands may show areas of mesenchymal, squamous, and/or sebaceous differentiation. 41, [47] [48] [49] [50] It has been suggested that squamous and mesenchymal elements are derived from myoepithelial cells. 51 Using isTILT, we found evidence for the origin of the K10-positive squamous lineage from K5/K14-positive progenitor cells, indicating striking similarities to normal squamous differentiation. Finally, sequential expression of K5/K14 and vimentin as mesenchymal marker in tumor cells of pleomorphic adenomas (in the absence of SMA or other myoepithelial markers) with chondroid changes, support the view that K5/K14-positive cells gradually differentiate to mesenchymal tissues in these tumors. These observations are in line with the view that pleomorphic adenomas arise from a single-cell type capable of divergent differentiation. 9 We believe that our findings might also explain how at least a part of metaplastic carcinomas with extracellular matrix of the breast may develop.
Based on the data discussed above, we propose a lineage differentiation model of look-alike tumors of the breast and salivary glands with myoepithelial differentiation ( Figure 5 ) using the epithelial cell models of human breast epithelium, 52-55 eccrine gland ducts, 56 and squamous epithelium, 57 However, despite the similarities between these look-alike tumors of the breast and salivary gland, many questions remain unresolved. Thus, most epithelial-myoepithelial tumors of the breast 58 are thought to possess only a borderline malignant potential, 43, [59] [60] [61] [62] whereas the same tumor in salivary glands, known as epithelial myoepithelial carcinoma, are clearly malignant. 45, [63] [64] [65] [66] Pure myoepithelial tumors have only rarely been reported in the breast 3, [67] [68] [69] [70] [71] and account for about 3% of all tumors of salivary glands. [72] [73] [74] [75] [76] The differential diagnosis include spindle cell tumors with glandular 72, [77] [78] [79] and/or squamous differentiation, 67 spindle cell adenocarcinomas, [80] [81] [82] [83] [84] and mesenchymal tumors. 37 Here, we have only studied one malignant myoepithelioma of the breast, which expressed K5/K14 and the myoid marker SMA, but not, or only focally and rather feebly, glandular keratins K7/K8/K18 and/or keratin K10.
Adenoid cystic carcinomas of both the breast and salivary glands are morphologically, immunophenotypically (see above), and genetically very similar. Thus, they are both characterized by the same recurrent t(6;9) translocation resulting in the MYB-NFIB gene fusion. 31, 85 Overexpression of the MYB oncogene is a hallmark of adenoid cystic carcinoma irrespective of anatomical location. 32, 85, 86 Despite these similarities, there are important differences between these tumors. Thus, adenoid cystic carcinomas of the breast are very rare (0.1-1% of all breast cancers 38 ) and have an excellent prognosis whereas adenoid cystic carcinomas of the salivary glands account for about 10% of epithelial tumors of the salivary glands and are a highly aggressive disease with a high recurrence rate and long-term Salivary gland-like tumors poor survival. 87, 88 The differences in clinical behavior are only partly known. Recent studies using high-resolution array-CGH have shown that adenoid cystic carcinomas of the breast have very few or no recurrent copy number alterations in line with their non-aggressive clinical appearance. 89 In contrast, salivary gland adenoid cystic carcinomas have multiple recurrent copy number alterations some of which are associated with a poor prognosis. 90, 91 Dedifferentiation and progression to high-grade lesions (no specific type grade 3, malignant myoepithelial, or of mixed epithelial-myoepithelial type) have been described both in salivary gland and breast tumors. 59, 71, [92] [93] [94] [95] [96] [97] It has been suggested that new genetic alterations gradually accumulate in subclones of these tumors leading to clonal evolution and disease progression. 31, [90] [91] [92] Based on our proposed lineage differentiation model ( Figure 5 ), it seems likely that in addition to specific genetic alterations, the cell lineage and the stage of differentiation of the cells undergoing 'dedifferentiation' are important factors that might influence this process.
A key to the understanding of proliferative diseases is the knowledge about the corresponding normal tissues. Our isTILT studies revealed that normal breast and salivary glands show striking similarities in their cellular composition. Both glands contain K5/K14/p63-positive progenitor cells, which give rise to glandular cells with subsequent downregulation of basal keratins/p63 and upregulation of glandular keratins K7/K8/18. Furthermore, it has been demonstrated for breast tissue that the myoepithelial cells originate (embryologically, in transplantation studies, and during physiological regeneration) from K5 and/or K14-positive progenitors 52, 53, 55 that co-express p63. 16 Our isTILT data provide support for similar cellular differentiation processes in the salivary gland (Boecker et al, manuscript in preparation). Based on these observations, we suggest that this unique population of K5/K14-and p63-positive progenitor cells of breast, salivary, and lacrimal glands form a core cell population that can spawn these different tumor phenotypes.
